• 1-Phenyl-2-Pentanol and Liver Fibrosis

  2026-10-06

  A 2024 study identified 1-phenyl-2-pentanol from Moringa oleifera leaves and evaluated its anti-fibrotic activity in TGF-β1-stimulated human hepatic stellate cells. The work connects reduced fibrosis-associated markers with changes in TGF-β and Wnt/β-catenin signaling, while remaining an in vitro, hypothesis-generating study rather than evidence of clinical efficacy.

• PLGA Microspheres for Cartilage Corticosteroid Delivery

  2026-10-06

  A 2026 Pharmaceutics study shows that PLGA microsphere size, surface chemistry, and corticosteroid stability jointly influence transport through articular cartilage. Its bovine explant, release, and HPLC evidence provides a framework for interpreting controlled intra-articular delivery while highlighting the limits of simple diffusion models.

• Angiotensin I/II (1-5) Product Overview

  2026-10-05

  APExBIO lists Angiotensin I/II (1-5) as an Asp-Arg-Val-Tyr-Ile peptide fragment for conceptual renin-angiotensin system research. No matched paper evidence was provided, so biological activity, performance, and application-specific outcomes remain unverified.

• PR-619: What the Evidence Supports

  2026-10-05

  PR-619 is described as a reversible, cell-permeable inhibitor of multiple cysteine-dependent deubiquitylating enzymes (DUBs). This overview separates supplier-reported properties from stronger evidence, explains conceptual applications in ubiquitination pathway research, autophagy, cancer biology and neurodegeneration, and highlights important limits in specificity, assay interpretation and translational relevance.

• BAPTA in Calcium Signaling and Apoptosis Research

  2026-10-04

  BAPTA is a calcium chelator used as a mechanistic probe in calcium signaling, apoptosis research, and cell signaling studies. A 2026 Toxicology study reported that polystyrene nanoplastic and cadmium co-exposure promoted intestinal-cell apoptosis through an IP3R/Ca²⁺/STAT3-associated response, while calcium chelation attenuated the outcome. These findings support calcium dysregulation as a contributor, but they do not establish that BAPTA selectively targets one pathway or that the results translate directly to human health.

• G007-LK: Translating Tankyrase Biology Into Strategy

  2026-10-03

  A source-grounded perspective on how G007-LK connects tankyrase biology with Wnt/β-catenin and Hippo signaling, and how translational researchers can assess its relevance across colorectal cancer and hepatocellular carcinoma models.

• InstaBlue Protein Stain Solution Protocol

  2026-10-02

  InstaBlue Protein Stain Solution provides a rapid, fixation-free method for visualizing protein bands after polyacrylamide gel electrophoresis. It is suited to routine protein electrophoresis analysis, gel excision, and comparative band assessment, but should not replace a validated quantitative assay or workflows that specifically require methanol/acetic acid fixation.

• L-Glutathione Reduced in GOT1 Translation

  2026-10-01

  A translational framework for using L-Glutathione Reduced to connect GOT1-dependent metabolism, redox-state measurements, GST workflows, and cancer research without confusing assay support with therapeutic efficacy.

• Farnesyl Alcohol Azide in KRAS Research

  2026-10-01

  Farnesyl Alcohol Azide provides a chemically distinctive entry point for studying farnesylation, KRAS condensates, and Ras processing. This article translates recent phase-separation findings into practical assay-design considerations while clearly separating validated biology from probe-development hypotheses.

• BV6 for Reliable Cell-Death Assays

  2026-09-30

  A scenario-based guide to using BV6 (SKU B4653) as an IAP antagonist in apoptosis, cytotoxicity, radiosensitization, and disease-model workflows. It connects mechanism, solvent handling, dose interpretation, and vendor-selection criteria to more defensible laboratory data.

• Farnesylation, KRAS Condensates, and Translation

  2026-09-30

  A mechanistic and translational perspective on how farnesylation-driven KRAS phase separation may reshape biomarker strategy, combination therapy, and chemical-biology workflows in colon cancer.

• Aligned Silk Fibroin–Ce6 Films for Infected Wounds

  2026-09-29

  The reference study developed an aligned silk fibroin film containing conjugated Chlorin e6 (Ce6) nanofibers, combining directional cell guidance with near-infrared photodynamic antibacterial activity. In an S. aureus wound model, the composite generated reactive oxygen species rapidly, reduced infection, and supported later-stage M2 macrophage polarization, illustrating how scaffold architecture and photochemistry can be integrated for wound repair.

• HyperPFU high-fidelity DNA polymerase for mRNA PCR

  2026-09-29

  Build cleaner, more accurate DNA templates for in vitro transcription, especially when long or GC-rich cassettes challenge routine PCR. HyperPFU™ combines proofreading fidelity, processivity, blunt-end generation, and inhibitor tolerance for mRNA research workflows that connect template preparation to downstream QC, LNP formulation, and cell transfection.

• Protein A/G Magnetic Co-IP/IP Kit Guide

  2026-09-28

  The Protein A/G Magnetic Co-IP/IP Kit uses recombinant Protein A/G magnetic beads for Fc region antibody binding, protein complex isolation, and downstream SDS-PAGE or mass spectrometry. Its magnetic workflow supports reproducible co-immunoprecipitation of protein complexes, but interaction claims require appropriate controls and orthogonal validation.

• Angiotensin (1-7): Mechanism and Research Evidence

  2026-09-28

  Angiotensin (1-7) is an endogenous heptapeptide that signals primarily through the Mas receptor and is studied for counter-regulatory effects on angiotensin II pathways. The sequence Asp-Arg-Val-Tyr-Ile-His-Pro links product identity to research on signaling, tissue responses, and an emerging in-vitro spike-protein binding observation.

8105 records 3/541 page Previous Next 12345 下5页 Last page